Following a demand for tissue development research, 3D bioprinting material provider Organovo (NASDAQ:ONVO) has reported a total revenue of $1.0 million for the first quarter of FY 2018, an 11% increase on the same period in 2017. With the results, the company also affirms its outlook for the full-year, expecting total revenue to reach $6.0 million – […]
from 3D Printing Industry
jueves, 10 de agosto de 2017
5:54
MR: EDITOR
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Related Posts